Oñate, Guadalupe http://orcid.org/0000-0003-2180-2371
Pratcorona, Marta
Garrido, Ana
Artigas-Baleri, Alicia
Bataller, Alex
Tormo, Mar http://orcid.org/0000-0001-9622-1649
Arnan, Montserrat
Vives, Susana
Coll, Rosa
Salamero, Olga http://orcid.org/0000-0003-3237-0025
Vall-Llovera, Ferran
Sampol, Antònia http://orcid.org/0000-0001-7465-6203
Garcia, Antoni
Cervera, Marta
Avila, Sara Garcia
Bargay, Joan
Ortín, Xavier
Nomdedéu, Josep F. http://orcid.org/0000-0003-3399-346X
Esteve, Jordi http://orcid.org/0000-0002-8056-648X
Sierra, Jorge http://orcid.org/0000-0002-7966-0356
,
Funding for this research was provided by:
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (PI17/01246, PI20/01621, CM20/00061)
Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya (SGR-Cat 2021)
Article History
Received: 10 February 2023
Revised: 5 April 2023
Accepted: 13 April 2023
First Online: 5 May 2023
Conflict of interest
: JS reports personal fees from AbbVie, Vyxeos, Gilead, CSL Behring, Astellas, and Gilead; grants and personal fees from Novartis and Daiichi-Sankyo; and grants from Amgen and Jazz Pharmaceuticals. JE reports consultancy-honoraria from Abbvie, Novartis, Astellas, Jazz Pharmaceuticals, BMS-Celgene, Pfizer, Daichii-Sankyo and research grants from Novartis and Jazz Pharmaceuticals. The remaining authors declare no competing financial interests.